Loading clinical trials...
Loading clinical trials...
A Phase I Study of Batracylin (NSC320846) in Subjects With Solid Tumors and Lymphomas
Conditions
Interventions
Batracylin
Locations
1
United States
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Start Date
February 24, 2007
Primary Completion Date
April 24, 2011
Completion Date
April 24, 2011
Last Updated
December 5, 2019
NCT00026884
NCT07213804
NCT07169851
NCT07159659
NCT07481851
NCT06662786
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions